I
Indaptus Therapeutics D
D
INDP
11.110
USD
0.32
(2.97%)
مغلق
حجم التداول
21
الربح لكل سهم
-38
العائد الربحي
-
P/E
-0
حجم السوق
6,362,230
العنوان: Indaptus Therapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.